Replies to post #92890 on Ocata Therapeutics Inc fka OCAT

[joecarry]

Ocata’s chief scientific officer to stay with Astellas following acquisition:

Robert Lanza, one of the most prominent scientists in the field of stem cell biology, Monday said he will lead global regenerative medicine research for Astellas Pharma Inc., the Japanese drug maker that acquired his Massachusetts-based company earlier this month.

Lanza said in an interview that he will also remain in his current role of chief scientific officer at Astellas-owned Ocata Therapeutics Inc. in Marlborough, which is developing stem cell therapies for a broad range of diseases.

https://www.bostonglobe.com/business/2016/02/22/ocata-chief-scientific-officer-join-astellas-head-global-regenerative-medicine/pptDFkpb3d6ei0b8x5PlKN/story.html